66 results match your criteria: "Centre of Chronic Immunodeficiency[Affiliation]"
Clin Exp Immunol
March 2012
Centre of Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany.
In order to build a common data pool and estimate the disease burden of primary immunodeficiencies (PID) in Europe, the European Society for Immunodeficiencies (ESID) has developed an internet-based database for clinical and research data on patients with PID. This database is a platform for epidemiological analyses as well as the development of new diagnostic and therapeutic strategies and the identification of novel disease-associated genes. Since its start in 2004, 13,708 patients from 41 countries have been documented in the ESID database.
View Article and Find Full Text PDFJ Immunol
February 2012
Centre of Chronic Immunodeficiency, University of Freiburg, Freiburg 79106, Germany.
Stromal interaction molecule 1 (STIM1) deficiency is a rare genetic disorder of store-operated calcium entry, associated with a complex syndrome including immunodeficiency and immune dysregulation. The link from the molecular defect to these clinical manifestations is incompletely understood. We report two patients with a homozygous R429C point mutation in STIM1 completely abolishing store-operated calcium entry in T cells.
View Article and Find Full Text PDFJ Infect
January 2012
Centre of Chronic Immunodeficiency, University Hospital Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany.
We present a rare case of hemophagocytic lymphohistiocytosis (HLH) in a 70 year-old male patient with previously well-controlled HIV infection. We could confirm HLH in different organs post mortem. Since the diagnosis of HLH was delayed, the patient died despite initiation of chemotherapy.
View Article and Find Full Text PDFCell Tissue Res
January 2012
Centre of Chronic Immunodeficiency, University Medical Centre Freiburg and University of Freiburg, 79106 Freiburg, Germany.
The brain function depends on a continuous supply of blood. The blood-brain barrier (BBB), which is formed by vascular cells and glia, separates components of the circulating blood from neurons and maintains the precisely regulated brain milieu required for proper neuronal function. A compromised BBB alters the transport of molecules between the blood and brain and has been associated with or shown to precede neurodegenerative disease.
View Article and Find Full Text PDFNephrol Dial Transplant
March 2012
Centre of Chronic Immunodeficiency, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Background: The etiology of nephrocalcinosis is variable. In this study, we wanted to elucidate whether the histopathological appearance of calcium phosphate deposits provides information about possible etiology.
Methods: Autopsy cases from the years 1988 to 2007 and native kidney biopsies from a 50-year period (1959-2008) with nephrocalcinosis were identified.
Susceptibility to respiratory syncytial virus (RSV) infection in mice is genetically determined. While RSV causes little pathology in C57BL/6 mice, pulmonary inflammation and weight loss occur in BALB/c mice. Using major histocompatibility complex (MHC)-congenic mice, we observed that the H-2(d) allele can partially transfer disease susceptibility to C57BL/6 mice.
View Article and Find Full Text PDFClin Immunol
October 2011
Centre of Chronic Immunodeficiency, University Hospital Freiburg, Breisacher Str. 117, D-79106 Freiburg, Germany.
Hypomorphic mutations in genes associated with severe combined immunodeficiency (SCID) or Omenn syndrome can also cause milder immunodeficiencies. We report 10 new patients with such "atypical" SCID and summarize 63 patients from the literature. The patient groups with T(low)B(low) (n=28), T(low)B(+) (n=16) and ADA (n=29) SCID variants had similar infection profiles but differed in the frequency of immune dysregulation, which was observed predominantly in patients with recombination defects.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
February 2011
Centre of Chronic Immunodeficiency and Centre for Pediatrics and Adolescent Medicine, University Medical Center Freiburg, 79106 Freiburg, Germany.
Lymphocytes mediate cytotoxicity by polarized release of the contents of cytotoxic granules toward their target cells. Here, we have studied the role of the calcium release-activated calcium channel ORAI1 in human lymphocyte cytotoxicity. Natural killer (NK) cells obtained from an ORAI1-deficient patient displayed defective store-operated Ca(2+) entry (SOCE) and severely defective cytotoxic granule exocytosis leading to impaired target cell lysis.
View Article and Find Full Text PDFEMBO Rep
January 2011
Centre of Chronic Immunodeficiency, Medical Centre, University Freiburg, Breisacherstrasse 117, Freiburg 79106, Germany.
Group B streptococcus (GBS) is a leading cause of both neonatal sepsis and meningitis, two diseases that are characterized by inflammation. However, the manner in which GBS organisms are recognized by monocytes and macrophages is poorly understood. In this study, we report that the recognition of GBS and other Gram-positive bacteria by macrophages and monocytes relies on bacterial single-stranded RNA (ssRNA).
View Article and Find Full Text PDFMedicine (Baltimore)
November 2010
From Study Center of Primary Immunodeficiencies, Assistance Publique Hôpitaux de Paris (CP); Necker Hospital, Paris, France. Laboratory of Human Genetics of Infectious Diseases (CP, HvB, PG, MC, CLK, L. Abel, AP, JLC), Necker Branch, INSERM U980, Paris, France. Paris Descartes University (CP, HvB, PG, MC, CLK, L. Abel, AP, JLC), Paris, France. Department of Pediatric Pneumology and Immunology (HvB), Charité Hospital-Humboldt University, Berlin, Germany. Prince Naif Center for Immunology Research (PG, SAM, SAH, AAG, JLC), College of Medicine, King Saud University, Riyadh, Saudi Arabia. Division of Infectious Diseases (OL); and Division of Immunology (DM, RSG), Children's Hospital Boston (OL), Boston, Massachusetts. Harvard Medical School (OL, DM, RSG), Boston, Massachusetts. University of Manchester (PDA), Royal Manchester Children's Hospital, Manchester, United Kingdom. Department of Pediatrics (HT, TH), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Department of Pediatrics (JCK, CBC), Division of Pediatric Infectious Diseases, Vanderbilt University, Nashville, Tennessee. Centre of Chronic Immunodeficiency (SE), University of Freiburg, Freiburg, Germany. Department of Infectious and Pediatric Immunology (LM), Medical and Health Science Center, University of Debrecen, Debrecen, Hungary. Department of Pediatrics (SAM, SAH, AAG), King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Department of Pediatrics (NKDG), Division of Allergy and Immunology, University of South Florida and All Children's Hospital, St. Petersburg, Florida. Laboratory of Clinical Infectious Diseases (SMH, JIG), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. University of Oxford and Oxford Radcliffe Hospital (HC), Oxford, United Kingdom. Division of Infectious and Immunological Diseases (DPS), Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada. Department of Immunology (CRG), Dr Negrin University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain. Department of Pediatrics (EC), Unit of Infectious Diseases, Insular-Materno-Infantil University Hospital, Las Palmas de Gran Canaria, Spain. Schneider Children's Medical Center (BZG), Petah Tiqva, Israel. Division of Immunology and Allergy (C. Roifman), Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Department of Neurology (HY), Miyagi Children's Hospital, Sendai, Japan. Department of Pediatrics (SN), National Defense Medical College, Saitama, Japan. Pediatrics, Microbiology and Immunology (JD), SUNY Upstate Medical University, Syracuse, New York. Dalhousie University (ACI), Halifax, Nova Scotia, Canada. Royal Children's Hospital (MT, JS), Parkville, Victoria, Australia. University Children Hospital Ljubljana (SEZ), Ljubljana, Slovenia. Unité transversale d'Allergologie, Néphrologie et Immunologie Clinique (CH), Centre hospitalier universitaire de Tours, Tours, France. Department of Clinical Biochemistry and Immunology (DSK, RD), Addenbrookes Hospital, Cambridge, United Kingdom. Paediatric Immunology and Molecular Immunology Unit (AJT), Institute of Child Health, London, United Kingdom. Department of Clinical Immunology (EGD), Great Ormond St Hospital, London, United Kingdom. Immunology Department (CB), Derriford Hospital,Plymouth, United Kingdom. University Hospital Archet 2 (NS), Nice, France. Lenval Foundation (DDR), Children's Hospital, Nice, France. Cerrahpasa Medical School (YC), Istanbul University, Istanbul, Turkey. Clinical Pathology and Pediatric Department (JV, MG), General Hospital of Santo António, Porto, Portugal. Pediatric Department (ABV), Hospital S. João, Porto, Portugal. Pediatric Department (C. Rodrigo, FA, MM), Germans Trias i Pujol Hospital,Barcelona Autonomous University, Barcelona, Spain. Immunology Department-CDB (JIA), Hospital Clínic-IDIBAPS, Barcelona University, Barcelona, Spain. Pediatric Department (L. Alsina, CF), Hospital Sant Joan de Deu, Barcelona University, Barcelona, Spain. Immunology Department (JR), Universitäts-Kinderspital Zürich, Zürich, Switzerland. Pediatrics and Microbiology and Molecular Genetics (JMV), Medical College of Wisconsin, Milwaukee, Wisconsin. Experimental Laboratory Medicine (XB), Department of Medical Diagnostic Sciences, Biomedical Science Group, Catholic University Leuven, Leuven, Belgium. St. Giles Laboratory of Human Genetics of Infectious Diseases (JLC), Rockefeller Branch, The Rockefeller University, New York, New York. Pediatric Hematology-Immunology Unit (JLC), Necker Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
Autosomal recessive interleukin-1 receptor-associated kinase (IRAK)-4 and myeloid differentiation factor (MyD)88 deficiencies impair Toll-like receptor (TLR)- and interleukin-1 receptor-mediated immunity. We documented the clinical features and outcome of 48 patients with IRAK-4 deficiency and 12 patients with MyD88 deficiency, from 37 kindreds in 15 countries.The clinical features of IRAK-4 and MyD88 deficiency were indistinguishable.
View Article and Find Full Text PDFCurr Opin Allergy Clin Immunol
December 2010
Centre of Chronic Immunodeficiency, University Medical Centre Freiburg, Freiburg, Germany.
Purpose Of Review: Patients with a primary antibody deficiency of unknown cause are usually allotted the diagnosis of common variable immunodeficiency (CVID), thus creating a genetically, immunologically, and clinically highly heterogeneous study population, that focuses the attention of many clinicians and researchers worldwide. The purpose of this review is to highlight the most important publications of the past year with an emphasis on novel findings in genetics and the immunophenotype of CVID.
Recent Findings: New gene defects associated with a CVID phenotype have been described in BAFF-R, CD81, and CD20 in single consanguineous families.
Clin Immunol
December 2010
Centre of Chronic Immunodeficiency, University Medical Centre, Freiburg, Germany.
Autoimmune lymphoproliferative syndrome (ALPS) is mainly caused by defects in the CD95 pathway. Raised CD3+TCRαβ+CD4-CD8- double negative T cells and impaired T cell apoptosis are hallmarks of the disease. In contrast, the B cell compartment has been less well studied.
View Article and Find Full Text PDFJ Immunol
June 2010
Division of Rheumatology and Clinical Immunology, Centre of Chronic Immunodeficiency, University Medical Centre, Freiburg, Germany.
Several lines of evidence have demonstrated B cell intrinsic activation defects in patients with common variable immunodeficiency (CVID). The rapid increase of intracellular free calcium concentrations after engagement of the BCR represents one crucial element in this activation process. The analysis of 53 patients with CVID for BCR-induced calcium flux identified a subgroup of patients with significantly reduced Ca2+ signals in primary B cells.
View Article and Find Full Text PDFHepatology
January 2010
Department of Medicine II, University of Freiburg, Germany.
Unlabelled: Human leukocyte antigen B27 (HLA-B27) is associated with protection in human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection. This protective role is linked to single immunodominant HLA-B27-restricted CD8+ T-cell epitopes in both infections. In order to define the relative contribution of a specific HLA-B27-restricted epitope to the natural course of HCV infection, we compared the biological impact of the highly conserved HCV genotype 1 epitope, for which the protective role has been described, with the corresponding region in genotype 3 that differs in its sequence by three amino acid residues.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
August 2009
Centre of Chronic Immunodeficiency and Division of Rheumatology and Clinical Immunology, University Medical Center Freiburg, 79106 Freiburg, Germany.
The homeostasis of circulating B cell subsets in the peripheral blood of healthy adults is well regulated, but in disease it can be severely disturbed. Thus, a subgroup of patients with common variable immunodeficiency (CVID) presents with an extraordinary expansion of an unusual B cell population characterized by the low expression of CD21. CD21(low) B cells are polyclonal, unmutated IgM(+)IgD(+) B cells but carry a highly distinct gene expression profile which differs from conventional naïve B cells.
View Article and Find Full Text PDFEMBO J
July 2009
Center for Pediatrics and Adolescent Medicine and Centre of Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg 79106, Germany.